Mark A. Klausner

Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ.

NMT Corp. provides mobile mapping and workforce automation software. Its services include scanning, print-on-demand, back file conversion, and filming. The firm''s products include MapAgile and FAAR3. The company was founded in 1942 and is headquartered in La Crosse, WI.

Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company was founded on July 21, 2003 and is headquartered in New York, NY.

Ethicon, Inc. develops and markets medical products and devices for surgery. It offers different types of services such as wound management, women's health, and cardiovascular surgery. The company was founded by George F. Merson in 1915 and is headquartered in Somerville, NJ.

ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK.

Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010.

CardioPolymers, Inc. provides novel biocompatible polymer implant therapies to treat cronic heart failures. The company was founded in 2003 and is headquartered in Laguna Hills, CA.

Cowen Prime Services LLC (CPS) is a broker-dealer headquartered in New York City. The firm is directly owned by Cowen PB Holdings LLC, which, in turn, is primarily owned by Cowen Group, Inc. (NASDAQ: COWN). CPS is registered as a broker-dealer with the SEC and FINRA, and as a an introducing broker with the Commodities Futures Trading Commission and the National Futures Association. CPS was formed in 2015 following Cowen Group’s acquisition of Concept Capital Markets LLC. Concept Capital was established in 2010 following the spin-off of the Concept Capital division of Sanders Morris Harris Inc., whose origins date back to 1995. CPS' offering includes world-class custody and clearing options, multi asset class capabilities, leading execution and order management systems, a seasoned execution desk, a range of financing options, a highly professional operations and customer support team, comprehensive portfolio reporting capabilities, capital introduction, and live, intraday and post-trade risk and performance analytics.

Part of Stryker Corp., Stryker Biotech LLC develops, manufactures and markets surgical and medical products. The company is based in Hopkinton, MA.

LifeSci Advisors LLC is an investor relations consultancy founded to provide companies in the life sciences a comprehensive solution to investor communications and outreach. Their services are designed to increase clients? visibility within the investment community and to educate investors about the opportunity.

Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA.

Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany.

Praetego, Inc. engages in development of amadorins for diabetic complications. The company was founded by Pepper Landson in 2017 and is headquartered in Durham, NC.

Algorithm Sciences, Inc. engages in the business of technology services. The company was founded in 2019 and is headquartered in New York, NY.

Kira Biotech Pty Ltd. operates as biotechnology company which develops novel immunomodulatory compounds for the treatment of immune system disorders. The company was founded by Georgina Clark is headquartered in Brisbane, Australia.

Voltron Therapeutics, Inc. develops the vaccine and immunotherapy center. The company was founded in 2017 and is headquartered in New York, NY.

Laidlaw Venture Partners (Laidlaw Venture) is a venture capital subsidiary of Laidlaw & Co(UK) Ltd. The firm is headquartered in New York.

Pd Theranostics, Inc. develops algorithms for prostate cancer and diabetic foot ulcers patience. The company is headquartered in New York, NY.

Aerwave Medical, Inc. is a company that is developing a unique alternative to traditional medications used to treat pulmonary diseases such as asthma and COPD. The company is based in New York, NY, and the CEO of the company is Jeffrey Francis O'Donnell. These diseases are characterized by an unmet medical need, with up to 15% of asthma patients and 25% of COPD patients being unresponsive to treatment. Additionally, around 50% of long-term inhaler users discontinue use within the first year due to compliance issues and multiple side effects. Aerwave Medical's revolutionary approach involves an interventional method to treat these diseases.

Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile.